Pages that link to "Q40272804"

The following pages link to Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors (Q40272804):

Displaying 45 items.

• Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis (Q24324662) (← links)
• Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion (Q28082707) (← links)
• ERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells. (Q30576405) (← links)
• Identification of proteins involved in neural progenitor cell targeting of gliomas (Q33475160) (← links)
• Differential expression of follistatin and FLRG in human breast proliferative disorders (Q33501385) (← links)
• Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer (Q33768293) (← links)
• Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer (Q34080323) (← links)
• DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. (Q34194526) (← links)
• Reduction of AUF1-mediated follistatin mRNA decay during glucose starvation protects cells from apoptosis (Q34249551) (← links)
• Nucleolar Follistatin Promotes Cancer Cell Survival under Glucose-deprived Conditions through Inhibiting Cellular rRNA Synthesis (Q34299252) (← links)
• A randomized phase II study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528 (Q34322552) (← links)
• Endothelial progenitor cell biology in disease and tissue regeneration (Q35069503) (← links)
• Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis (Q35167976) (← links)
• The Local Control of the Pituitary by Activin Signaling and Modulation (Q35214837) (← links)
• Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes. (Q35571688) (← links)
• Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response (Q35639228) (← links)
• BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells (Q36003520) (← links)
• Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin (Q36007410) (← links)
• Esophageal squamous cell carcinoma invasion is inhibited by Activin A in ACVRIB-positive cells (Q36187837) (← links)
• Female infertility and disrupted angiogenesis are actions of specific follistatin isoforms (Q36447463) (← links)
• Serum Levels of Follistatin Are Positively Associated With Serum-Free Thyroxine Levels in Patients With Hyperthyroidism or Euthyroidism (Q36566934) (← links)
• Morphologic changes of mammary carcinomas in mice over time as monitored by flat-panel detector volume computed tomography. (Q36730941) (← links)
• SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma (Q37113106) (← links)
• Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes (Q37205669) (← links)
• Clinical and Therapeutic Implications of Follistatin in Solid Tumours. (Q37569979) (← links)
• Follistatin as a potent regulator of bone metabolism. (Q37766879) (← links)
• The role of activin in mammary gland development and oncogenesis (Q37863042) (← links)
• Follistatin as potential therapeutic target in prostate cancer (Q38086102) (← links)
• Activin A is anti-lymphangiogenic in a melanoma mouse model (Q38969569) (← links)
• Prognotic impact of serum follistatin in patients with hepatocellular carcinoma (Q39463161) (← links)
• Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis (Q40191493) (← links)
• Segregation of late outgrowth endothelial cells into functional endothelial CD34- and progenitor-like CD34+ cell populations (Q40225619) (← links)
• Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients. (Q40535967) (← links)
• Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival (Q41525852) (← links)
• Follistatin and the Breast Implant Capsule (Q42290557) (← links)
• Serum follistatin in patients with prostate cancer metastatic to the bone. (Q42972965) (← links)
• Transcriptional profile of Rous Sarcoma Virus transformed chicken embryo fibroblasts reveals new signaling targets of viral-src (Q43156526) (← links)
• Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report. (Q51498595) (← links)
• Multicellular spheroids as an in vitro model in experimental oncology: applications in translational medicine. (Q53585874) (← links)
• Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma. (Q53794062) (← links)
• Association of serum follistatin levels with histological types and progression of tumor in human lung cancer (Q58120657) (← links)
• Follistatin Effects in Migration, Vascularization, and Osteogenesis in vitro and Bone Repair in vivo (Q64076525) (← links)
• A paracrine activin A-mDia2 axis promotes squamous carcinogenesis via fibroblast reprogramming (Q90158913) (← links)
• Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors (Q91404934) (← links)
• The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer (Q92385082) (← links)